Rochester, NY 9/1/2009 8:31:03 AM
Cerus Corporation, CERS, Down by 0.02 cents in Afternoon Trading
Cerus Corporation
Shares of Cerus Corp rose as much as 17 percent after Avondale Partners upgraded the blood-safety products maker to 'market outperform' from 'market perform,' citing wider product acceptance and regulatory advancements.
Cerus Intercept blood system, for treating platelet and plasma components, is viewed by the American Association of Blood Banks (AABB) as an effective way to prevent the transmission of infectious diseases through transfusions, analyst Daniel Owczarski said, citing the lead author of AABB's monthly journal.
Whisperfromwallstreet.com is a FREE award winning newsletter dedicated to uncovering stocks that are about to move. Please click here to join now.
Last Trade: 2.11
Day's Range: 2.08 - 2.20
52wk Range: 0.55 - 5.02
Change: Down 0.02 (0.94%)
Volume: 807,306
Avg Vol (3m): 1,066,260
ABOUT Cerus Corporation
Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System. The company's INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. It markets the INTERCEPT system for platelets and plasma primarily in Europe, the Russian Federation, and the Middle East. The company is also developing INTERCEPT Blood System for red blood cells or red blood cell system, which is designed to inactivate blood-borne pathogens in donated red blood cells for transfusion. It has collaboration agreements with Baxter International, Inc., BioOne Corporation, and Laboratorios Grifols S.A., as well as the United States Armed Forces. The company was founded in 1991 and is based in Concord, California.
ABOUT WhisperFromWallStreet.com
WhisperFromWallStreet.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
WhisperFromWallStreet.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://WhisperFromWallStreet.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
